Spacewalking astronauts prep for 2021 arrival of Russian lab

CAPE CANAVERAL: The International Space Station’s two Russian astronauts began spacewalking work Wednesday to prepare for next year’s arrival of a long-delayed lab, but had to scrap another chore because of a stubborn bolt. Sergey...

Ventilators lying idle thanks to lack of experts

DHANGADI, NOVEMBER 18 Ventilators worth millions of rupees bought by the Sudurpaschim Province Government have been stored in various health facilities of the province due to the lack of manpower to operate them and places...

Sandeep Lamichhane joins Hobart Hurricanes for BBL

KATHMANDU: Nepali leg-spinner Sandeep Lamichhane on Wednesday joined the Hobart Hurricanes of the Big Bash League (BBL) for the upcoming season. The 20-year-old leg-spinner is the first Nepalese cricketer to play in the BBL. In his...

Achievements of struggle at risk: Yadav

RAJBIRAJ, NOVEMBER 18 Janata Samajwadi Party Chairperson Upendra Yadav has called on the nation to stand guard against the possibility of losing the hardearned achievements of people’s struggles. “As to how the government is faring, it...

Lumbini opens doors to tourists

BHAIRAHAWA, NOVEMBER 18 After being closed down for seven months due to the pandemic, Lumbini, a major tourist destination, has opened its doors to tourists from today. Lumbini Development Fund Member Secretary Sanuraja Shakya said that...

MoCTCA begins preparations for resuming tourist activities

KATHMANDU, NOVEMBER 18 The Ministry of Culture, Tourism and Civil Aviation (MoCTCA) has started preparations to resume remaining tourist activities in the country. As the Cabinet has decided to allow operations of cable cars, jungle safaris...

Sit-in for opening border point continues

RAUTAHAT, NOVEMBER 18 Cadres and leaders of Nepali Congress and Janata Samajwabi Party gave continuity to the sit-in in front of Gaur Customs Office in Rauathat today as well. People staging a sit-in in front of...

Pfizer-BioNTech vaccine deliveries could start ‘before Christmas’

Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side effects, the drugmakers...